Next Article in Journal
Impact of SGLT2-Inhibitor Therapy on Survival in Patients with Transthyretin Amyloid Cardiomyopathy: Analysis of a Prospective Registry Study
Previous Article in Journal
Double Row Hip Abductor Reconstruction with Fasciae Latae Transfer for Severe Trendelenburg after Hip Arthroplasty
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Rotator Cuff Tear Size: Could It Be Influenced by the Presence of One or More Diseases Capable of Altering the Peripheral Microcirculation?

1
Sapienza University of Rome, 00161 Rome, Italy
2
Incheon Catholic University, Incheon 21987, Republic of Korea
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2024, 13(19), 5965; https://doi.org/10.3390/jcm13195965
Submission received: 29 August 2024 / Revised: 1 October 2024 / Accepted: 2 October 2024 / Published: 7 October 2024
(This article belongs to the Section Orthopedics)

Abstract

:
Background: To date, it is not well known which systemic pathologies most frequently afflict patients with rotator cuff tear (RCT) and whether the coexistence of two or more pathologies can affect the lesion size. Therefore, we analyzed our database relative to a large group of patients who recently underwent rotator cuff repair. Methods: A total of 527 patients with full-thickness RCT were enrolled. For each patient, we checked the presence of at least one of diabetes, venous system diseases, cardiovascular diseases, hypercholesterolemia, blood hypertension, thyroid diseases, and a smoking habit. Patients were subdivided according to risk factors into five groups, representing those who had zero, one, two, three, and four or more risk factors, respectively. Statistical analysis was performed. Results: In total, 37% of our patients had no risk factors; 28% had one risk factor (arterial hypertension, smoking habit, and hypercholesterolemia were the most frequent); 23% had two risk factors (the hypertension/hypercholesterolemia association was the most frequent); and 8% suffered from three pathologies (the diabetes/arterial hypertension/hypercholesterolemia association was the most frequent). Comparing the cuff tear severity in patients without and with at least one risk factor, we observed that tear size increased in those with at least one risk factor. Conclusions: A total of 63% of patients with rotator cuff tears were either smokers and/or had at least one pathology capable of altering the peripheral microcirculation. Hypertension and hypercholesterolemia were the most frequent. Tear severity significantly increased with the presence of at least one risk factor.

1. Introduction

Degeneration and subsequent tearing of the rotator cuff (RC) have recently been attributed primarily to tissue physiological senescence and intrinsic factors, relegating extrinsic factors (such as acromion shape, slope, index, and coverage; critical shoulder angle; and acromio-clavicular deformity) to a marginal and secondary role [1,2,3,4]. Medical conditions (comorbidities) and unhealthy habits are considered the principal risk factors. Hypercholesterolemia [3,4,5], metabolic syndrome and resultant obesity [6], uncontrolled arterial hypertension [7,8], and diabetes [3,9,10] have been implicated in the pathogenesis of cuff degeneration, tearing, and re-tearing [11]. Smoking [12] and excessive alcohol consumption [13], regardless of the quality and quantity of food, are behaviors indicative of an unhealthy lifestyle. It is not uncommon for individuals to exhibit multiple intrinsic risk factors, as certain medical conditions may arise as a consequence of these habits.
The link between these medical conditions and lifestyle habits and the degeneration and tearing of the rotator cuff lies in their predisposition to peripheral microcirculatory alterations. Rothman and Parke [14], as well as Chansky and Iannotti [15], have highlighted the significant role of hypovascularity in the genesis of cuff degeneration and tearing [3,4,5].
While recent studies [3,4,5,6,7,8,9,10,11] have examined the impact of these pathologies on shoulder tendons, it remains unclear which systemic pathologies most frequently afflict patients with cuff tears and whether the coexistence of multiple pathologies affects tear size. Therefore, we conducted an analysis using our database of consecutive patients who underwent rotator cuff repair. We collected personal data, anthropometric characteristics, information on systemic diseases and lifestyle habits, cuff tear size, and details of the surgical treatment administered to each patient in order to evaluate the possible correlation between RC tear severity and comorbidities. Our hypothesis was that the presence of systemic pathologies directly affects the rotator cuff tear dimension.

2. Materials and Methods

2.1. Patient Enrollment

A consecutive series of 527 patients who underwent surgery for full-thickness rotator cuff tears from January 2019 and December 2023 were enrolled, with ages ranging from 37 to 80 years (mean age: 60.16 years).
The diagnosis was performed through physical examination and both X-ray and MRI of the affected shoulder. Among them, 37 patients (7%) reported that they began to experience shoulder problems only after direct trauma or sudden traction along the limb axis. The presence of one of the following seven risk factors was investigated for each patient: diabetes, venous system diseases, cardiovascular diseases, hypercholesterolemia, hypertension, thyroid diseases, and a smoking habit. Exclusion criteria included moderate or severe osteoarthritis of the operated or contralateral shoulder (Hamada 3 or more), prior shoulder surgery, subscapularis tendon tears, history of shoulder dislocations, concurrent or previous frozen shoulder, or inflammatory joint disease.

2.2. Arthroscopic Evaluation

All arthroscopic procedures were performed by one of the authors (SG) with patients under general anesthesia and interscalene block, in the beach-chair position. The Southern California Orthopedic Institute classification was used intraoperatively to classify rotator cuff tears [16]: (1) A small, complete tear, such as a puncture wound or a tear (usually <2 cm), that involves only 1 rotator cuff tendon, with no retraction of the torn ends. (2) A large, complete tear involving an entire tendon, with minimal retraction of the torn edge, usually 3 to 4 cm; and finally, (3) a massive rotator cuff tear involving 2 rotator cuff tendons, often with associated retraction and scarring of the remaining tendon ends, and frequently an irreparable L-shaped tear.

2.3. Groups

Patients were divided into groups based on the number of comorbidities they had, resulting in 5 groups: those with 0, 1, 2, 3, and 4 or more risk factors, respectively. Except for those with no risk factors, each group was subdivided considering all possible groupings of risk factors: 7 for 1 risk factor, 21 couples for 2 risk factors, and 35 triples for 3 risk factors. For each group, the number of small, large, and massive rotator cuff tears was counted to assess the influence of the risk factors on the severity of the lesions.

2.4. Statistical Analyses

The number of possible couples and triples can be derived by combinatorics. Indeed, the possible distinct couples and triples obtained from 7 risk factors are, respectively,  7 2 = 7 ! 2 ! 7 2 ! = 5040 2 120 = 21  and  7 3 = 7 ! 3 ! 7 3 ! = 5040 6 24 = 35 . As far as the statistical analysis is concerned, all data have been tested against the null hypothesis that the risk factors (or couples, or triples of risk factors) were evenly distributed in the population of patients, using a two-sided p-value on the samples. The statistically significant values were those with p < 0.05.
IRB: not applicable, since a standard surgical procedure has been performed and data are collected ensuring anonymity.

3. Results

3.1. Patient Characteristics

Table 1 shows the subdivision of patients according to the number of risk factors, while Figure 1 shows the subdivision of patients according to tear size.
Among people with cuff tear and 1 risk factor (Table 2), which represent 27.7% of the sample, the most representative comorbidities were blood hypertension (51 patients, 35.4%), a smoking habit (29 patients, 20.1%), and hypercholesterolemia (27 patients, 18.8%).

3.2. Comorbidities and Cuff Tear

Cuff tear dimension in patients with blood hypertension was small in 12 cases (23.5%), large in 18 cases (35.3%), and massive in 21 cases (41.2%), respectively. A similar preponderance of large and massive tears was present in people with a smoking habit, whose lesions were small (8 patients), large (7 patients), and massive (14 patients).

3.3. Group Analysis

Analyzing people with exactly 2 risk factors (Table 3), which represent 23.3% of the sample, we found that the couple blood hypertension/hypercholesterolemia was present in 36 cases (29.3%), followed by blood hypertension/cardiovascular disease coupled with 18 cases (14.6%). Other couples with more than 8% of the cases were a smoking habit/hypercholesterolemia, a smoking habit/blood hypertension, diabetes/blood hypertension, and thyroid diseases/blood hypertension. As far as the gravity of the tear is concerned, in the blood hypertension/hypercholesterolemia couple, the subdivision was small with 12 (33.3%), large with 18 (50.0%), and massive with 6 (16.7%).
In our series, 43 patients (8.2%) suffered from 3 pathologies (Table 4). The most representative subgroups were diabetes/blood hypertension/hypercholesterolemia (8 cases, 18.6%), thyroid diseases/blood hypertension/hypercholesterolemia (7 cases, 16.3%), and cardiovascular diseases/blood hypertension/hypercholesterolemia (5 cases, 11.6%). In these 3 larger subgroups, which showed greater statistical significance with respect to the others, tear severity was evenly distributed among small and large/massive (9 patients with a small tear, and 5 and 6 with large and massive tears, respectively).
As far as the 23 patients with 4 or more risk factors (17 with 4 factors, 6 with 5 factors), we did not analyze the subdivisions since a large number of possible groupings (35 for 4 factors, and 21 for 5) would have shown results with little or no statistical significance. Of these patients, 8 (34.8%) had a massive tear.
Among the patients with at least one risk factor, 58.2% suffered from blood hypertension, and 40.5% from hypercholesterolemia, with the couple hypercholesterolemia/blood hypertension accounting for 39.2% of the patients with at least two risk factors.
Comparing the severity in people without and with at least one risk factor (Table 5), we observed that tear size increased when at least one risk factor was present. In fact, a small tear, according to Southern California Orthopedic Institute was observed in half of the patients who had no associated pathologies and in only a third of those with one or more risk factors. The cuff tear was large or massive in 50% and 66% of patients without and with risk factors, respectively. Table 6 shows the percentage of patients with a massive cuff tear depending on the number of risk factors.

4. Discussion

Thirty-seven percent of patients in our series did not have any of the systemic diseases we analyzed and that are usually considered as risk factors for cuff degeneration and tear. Therefore, in our series, responsibility for cuff tears among those who did not have a known medical condition could be mainly due to genetics [17], morphological and morphometric characteristics of the shoulder bones [18,19,20], and trauma [21], and only marginally to physiological tissue aging [22], since the average age of these patients was significantly lower than that of patients with one or more medical conditions. It is also plausible that in patients without risk factors, some disorders may have not yet manifested themselves, or have not yet been diagnosed, but are already causing damage to their target organs. On the other hand, 73% of our patients were affected by at least one pathology among those that in the literature are considered risk factors for cuff degeneration/tear. Of the pathologies that we considered, venous system diseases, thyroid diseases, and cardiovascular diseases are not among those that more often afflict patients with rotator cuff tears. While the first two pathologies have been recognized as having a marginal role in the genesis of tendon degeneration [21,23], cardiovascular diseases often represent the unfortunate consequence of diabetes, hypercholesterolemia, and hypertension; therefore, it can be deduced that patients with cardiovascular pathologies were not well represented in our series because they were recognized by anesthesiologists as unsuitable for surgery.
In our series, patients with only one risk factor frequently had blood hypertension or hypercholesterolemia or were smokers. What these risk factors have in common is tissue hypoxia, induced by alterations in the peripheral microcirculation, which appears to be a critical link [24]. Hypoxia is a crucial factor in cuff degeneration as it triggers the formation of reactive oxygen species, leading to apoptosis and a shift in cellular metabolism towards glycolysis [25,26]. These changes determine the production of intermediates such as succinate and lactic acid, which in turn enhance the secretion of interleukins (IL-6,23-1β). Hypoxia is also responsible for the downregulation of type I collagen genes and an increase in type III collagen genes in tenocytes, disrupting collagen I homeostasis [27]. Thankam and Agrawal [27], in a brilliant paper, stated that these medical conditions exacerbate these processes, thereby accelerating tendon senescence. An accumulation of reactive oxygen species causes tenocyte apoptosis through the action of mediators like cytokines, Jun N-kinase, and metalloproteinases. Over time, apoptosis results in matrix degeneration, reduced collagen synthesis, decreased mechanical tendon resistance, and, consequently, tissue degeneration and tear. These pathologies may also impact endothelial function by altering the mechanism of regulation of the bioavailability of nitric oxide [28]; the change in this mechanism is crucial because nitric oxide is the major responsible for the maintenance of vascular homeostasis in endothelial cells.
In a brilliant systematic review and meta-analysis, Giri et al. [10] stated that diabetes, hypertension, and hyperlipidemia were associated with rotator cuff; however, the possibility of bias exists for all three co-morbidities and is likely higher for hypertension. Actually, the latter bias arises because arterial hypertension is a difficult and subtle pathology to study since, as it is often asymptomatic, the diagnosis can be delayed. Furthermore, it is conceivable that in the period between the onset of symptoms and the start of pharmacological therapy, the tissues suffered an ischemic insult responsible for tendon degeneration. Furthermore, some of the most used pharmacologic therapy angiotensin-converting enzyme (ACE) inhibitors, b-blockers, and angiotensin-II receptor antagonists work more on the great vessels than on the microcirculation [10]; therefore, in patients who use these drugs, the cuff tissue continues to be in a state of hypoxia, leading to tendon degeneration. This would also explain why among those who have only one risk factor, patients with blood hypertension are those who have wider tendon tears. We have observed a similar preponderance of large and massive tears in patients with a smoking habit. Related to this, in an observational study, Baumgarten et al. [12] showed that cigarette smoking increases the risk of rotator cuff tears and their severity.
When analyzing the group of patients with two disorders, blood hypertension is almost constantly present; furthermore, the number of patients with hypertension exponentially increases when it is associated with a smoking habit (about 8%), cardiovascular diseases (about 15%), and hypercholesterolemia (about 30%), respectively. Once again, the data lead us to consider that the impairment of the peripheral microcirculation is at the basis of cuff degeneration/tear and that the association of multiple diseases also affects the tear size. In fact, in our series, patients with hypertension and hypercholesterolemia had a large or massive tear in two-thirds of the cases. Furthermore, hypertension and hypercholesterolemia were the two pathologies that we most often observed in the group of patients with three pathologies.
Finally, we observed that the severity of the tear increases with the presence of at least one risk factor.
It is completely new information that the percentage of massive tears in patients with four risk factors is more than double that observed in patients without risk factors.
The present findings underline the fundamental role of intrinsic factors and peripheral hypoperfusion in the genesis and progression of RC degeneration and tear; furthermore, it reiterates the importance of early diagnosis and treatment, especially in patients with multiple comorbidities, because this avoids the tear progression with the possible risk of high rate of re-tear or surgical failures.
Data collection regarding comorbidities is a limitation of the study: no information is present regarding the time from the diagnosis of systemic diseases nor the adhesion of the therapy; however, the effects of hypoxia have been demonstrated to be present since the beginning of the condition, as mentioned above. Furthermore, no information is present regarding alcohol consumption and obesity, which are two documented risk factors for RC degeneration, and regarding RC fatty infiltration or retraction.

5. Conclusions

A total of 63% of patients with rotator cuff tears were either smokers and/or had at least one pathology capable of altering the peripheral microcirculation. Of the systemic pathologies, the most frequently encountered were blood hypertension and hypercholesterolemia. Furthermore, we observed that the severity of the tear increased with the presence of at least one risk factor; the percentage of massive tears in patients with four risk factors was more than double that observed in patients without risk factors.

Author Contributions

Methodology, L.O. and D.B.; Resources, H.-S.S.; Data curation, L.O. and D.B.; Writing—original draft, S.G., L.O. and V.C.; Writing—review & editing, V.C.; Supervision, S.G., H.-S.S. and H.K. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

We hereby certify that the manuscript entitled “Rotator Cuff Tear Size: Could It Be Influenced by the Presence of One or More Diseases Capable of Altering the Peripheral Microcirculation?”, does not need any ethical committee approval since a standard surgical procedure has been performed and data are collected ensuring anonymity.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Abboud, J.A.; Kim, J.S. The effect of hypercholesterolemia on rotator cuff disease. Clin. Orthop. Relat. Res. 2010, 468, 1493–1497. [Google Scholar] [CrossRef] [PubMed]
  2. Abtahi, A.M.; Granger, E.K.; Tashjian, R.Z. Factors affecting healing after arthroscopic rotator cuff repair. World J. Orthop. 2015, 6, 211–220. [Google Scholar] [CrossRef] [PubMed]
  3. Lin, T.T.; Lin, C.; Chang, C.; Chi, C.; Chang, S.; Sheu, W.H. The effect of diabetes, hyperlipidemia, and statins on the development of rotator cuff disease: A nationwide, 11-year, longitudinal, population-based follow-up study. Am. J. Sports Med. 2015, 43, 2126–2132. [Google Scholar] [CrossRef] [PubMed]
  4. Garcia, G.H.; Liu, J.N.; Wong, A.; Cordasco, F.; Dines, D.M.; Dines, J.S.; Gulotta, L.V.; Warren, R. Hyperlipidemia increases the risk of retear after arthroscopic rotator cuff repair. J. Shoulder Elb. Surg. 2017, 26, 2086–2090. [Google Scholar] [CrossRef]
  5. Fang, W.; Sekhon, S.; Teramoto, D.; Fung, C.; La, V.; Duong, C.; Doescher, C.; Thai, A.; Thankam, F.G.; Agrawal, D.K. Pathological alterations in the expression status of rotator cuff tendon matrix components in hyperlipidemia. Mol. Cell. Biochem. 2023, 478, 1887–1898. [Google Scholar] [CrossRef] [PubMed]
  6. Abate, M.; Di Carlo, L.; Salini, V.; Schiavone, C. Risk factors associated to bilateral rotator cuff tears. Orthop. Traumatol. Surg. Res. 2017, 103, 841–845. [Google Scholar] [CrossRef] [PubMed]
  7. Park, H.B.; Gwark, J.Y.; Im, J.H.; Jung, J.; Na, J.B.; Yoon, C.H. Factors Associated with Atraumatic Posterosuperior Rotator Cuff Tears. J. Bone Jt. Surg. Am. 2018, 100, 1397–1405. [Google Scholar] [CrossRef]
  8. Applegate, K.A.; Thiese, M.S.; Merryweather, A.S.; Kapellusch, J.; Drury, D.L.; Wood, E.; Kendall, R.; Foster, J.; Garg, A.; Hegmann, K.T. Association Between Cardiovascular Disease Risk Factors and Rotator Cuff Tendinopathy: A Cross-Sectional Study. J. Occup. Environ. Med. 2017, 59, 154–160. [Google Scholar] [CrossRef] [PubMed]
  9. Lu, X.; Sun, H.; Xu, Y.; Cao, X. The Influence of Diabetes Mellitus on Rotator Cuff Repair: A Systematic Review and Meta-Analysis. Comb. Chem. High Throughput Screen. 2021, 24, 908–920. [Google Scholar] [CrossRef]
  10. Giri, A.; O’Hanlon, D.; Jain, N.B. Risk factors for rotator cuff disease: A systematic review and meta-analysis of diabetes, hypertension, and hyperlipidemia. Ann. Phys. Rehabil. Med. 2023, 66, 101631. [Google Scholar] [CrossRef]
  11. Kilinc, O.; Ertem, K.; Ergen, E.; Aslanturk, O. What are the Factors that Impact the Outcomes of Arthroscopic Rotator Cuff Repair? Niger J. Clin. Pract. 2024, 27, 483–488. [Google Scholar] [CrossRef] [PubMed]
  12. Baumgarten, K.M.; Gerlach, D.; Galatz, L.M.; Teefey, S.A.; Middleton, W.D.; Ditsios, K.; Yamaguchi, K. Cigarette smoking increases the risk for rotator cuff tears. Clin. Orthop. 2010, 468, 1534–1541. [Google Scholar] [CrossRef] [PubMed]
  13. Passaretti, D.; Candela, V.; Venditto, T.; Giannicola, G.; Gumina, S. Association between alcohol consumption and rotator cuff tear. Acta Orthop. 2016, 87, 165–168. [Google Scholar] [CrossRef]
  14. Rothman, R.H.; Parke, W.W. The vascular anatomy of the rotator cuff. Clin. Orthop. Relat. Res. 1965, 41, 176–186. [Google Scholar]
  15. Chansky, H.A.; Iannotti, J.P. The vascularity of the rotator cuff. Clin. Sports Med. 1991, 10, 807–822. [Google Scholar] [CrossRef]
  16. Snyder, S.J. Arthroscopic classification of rotator cuff lesions and surgical decision making. In Shoulder Arthroscopy, 2nd ed.; JB Lippincott: Philadelphia, PA, USA, 2002; p. 204. [Google Scholar]
  17. Gumina, S.; Villani, C.; Arceri, V.; Fagnani, C.; Nisticò, L.; Venditto, T.; Castagna, A.; Candela, V. Rotator Cuff Degeneration: The Role of Genetics. J. Bone Jt. Surg. Am. 2019, 101, 600–605. [Google Scholar] [CrossRef]
  18. Bigliani, L.U.; Morrison, D.S.; April, E.W. The morphology of the acromion and its relationship to rotator cuff tears. Ortho Trans. 1986, 10, 228. [Google Scholar]
  19. Kitay, G.S.; Iannotti, J.P.; Williams, G.R.; Haygood, T.; Kneeland, B.J.; Berlin, J. Roentgenographic assessment of acromial morphologic condition in rotator cuff impingement syndrome. J. Shoulder Elbow Surg. 1995, 4, 441–448. [Google Scholar] [CrossRef]
  20. Nyffeler, R.W.; Werner, C.M.L.; Sukthankar, A.; Schmid, M.R.; Gerber, C. Association of a large lateral extension of the acromion with rotator cuff tears. J. Bone Jt. Surg. Am. 2006, 88, 800–805. [Google Scholar]
  21. Gumina, S.; Mezzaqui, L.; Aimino, R.; Rionero, M.; Spagnoli, A.; Campagna, V.; Candela, V. Aetiopathogenesis of rotator cuff tear in patients younger than 50 years: Medical conditions play a relevant role. Medicina 2023, 59, 998. [Google Scholar] [CrossRef]
  22. Liu, Y.; Li, X.; Jiang, L.; Ma, J. Identification of age-related genes in rotator cuff tendon. Bone Jt. Res. 2024, 13, 474–484. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  23. Oliva, F.; Berardi, A.C.; Misiti, S.; Verga Falzacappa, C.; Iacone, A.; Maffulli, N. Thyroid hormones enhance growth and counteract apoptosis in human tenocytes isolated from rotator cuff tendons. Cell Death Dis. 2013, 4, e705. [Google Scholar] [CrossRef]
  24. Gumina, S.; Song, H.S.; Kim, H.; Candela, V. Arthroscopic evaluation of the rotator cuff vasculature: Inferences into the pathogenesis of cuff tear and re-tear. Clin. Shoulder Elb. 2024, 27, 203. [Google Scholar] [CrossRef] [PubMed]
  25. McGarry, T.; Biniecka, M.; Veale, D.J.; Fearon, U. Hypoxia, oxidative stress and inflammation. Free Radic. Biol. Med. 2018, 125, 15–24. [Google Scholar] [CrossRef] [PubMed]
  26. Gumina, S.; Kim, H.; Jung, Y.; Song, H.S. Rotator cuff degeneration and healing after rotator cuff repair. Clin. Shoulder Elb. 2023, 26, 323–329. [Google Scholar] [CrossRef]
  27. Thankam, F.G.; Agrawal, D.K. Hypoxia-driven secretion of extracellular matrix proteins in the exosomes reflects the asymptomatic pathology of rotator cuff tendinopathies. Can. J. Physiol. Pharmacol. 2021, 99, 224–230. [Google Scholar] [CrossRef]
  28. Ambrosino, P.; Grassi, G.; Maniscalco, M. Endothelial dysfunction: From a pathophysiological mechanism to a potential therapeutic target. Biomedicines 2021, 10, 78. [Google Scholar] [CrossRef]
Figure 1. Subdivision of patients according to tear size.
Figure 1. Subdivision of patients according to tear size.
Jcm 13 05965 g001
Table 1. The studied group.
Table 1. The studied group.
No. of Risk FactorsNo. of Patients%Mean Age
019436.856.8
114427.360.1
212323.363.5
3438.264.1
≥4234.463.9
Table 2. Distribution of patients with one risk factor (* = p < 0.05).
Table 2. Distribution of patients with one risk factor (* = p < 0.05).
Risk FactorNo. of Patients% of PatientsTear Size (S, L, M)
diabetes85.56 *4, 2, 2
venous system diseases42.78 *3, 1, 0
cardiovascular diseases106.94 *5, 4, 1
hypercholesterolemia2718.75 *14, 8, 5
blood hypertension5135.42 *12, 18, 2
thyroid diseases1510.42 *7, 5, 3
smoking habit2920.14 *8, 7, 14
Table 3. Distribution of patients with two risk factors (* = p < 0.05).
Table 3. Distribution of patients with two risk factors (* = p < 0.05).
Risk Factor 1Risk Factor 2No. of Patients% of PatientsTear Size
(S, L, M)
diabetesvenous system diseases00.00 *0, 0, 0
diabetescardiovascular diseases21.63 *0, 0, 2
diabeteshypercholesterolemia32.44 *2, 0, 1
diabetesblood hypertension118.94 *4, 4, 3
diabetesthyroid diseases00.00 *0, 0, 0
diabetessmoking habit10.81 *1, 0, 0
venous system diseasecardiovascular diseases10.81 *0, 1, 0
venous system diseaseshypercholesterolemia21.63 *0, 2, 0
venous system diseasesblood hypertension32.44 *1, 1, 1
venous system diseasesthyroid diseases10.81 *0, 1, 0
venous system diseasessmoking habit00.00 *0, 0, 0
cardiovascular diseaseshypercholesterolemia32.44 *1, 0, 2
cardiovascular diseasesblood hypertension1814.63 *6, 6, 6
cardiovascular diseasesthyroid diseases21.63 *1, 1, 0
cardiovascular diseasessmoking habit10.81 *1, 0, 0
hypercholesterolemiablood hypertension3629.27 *12, 18, 6
hypercholesterolemiathyroid diseases54.070, 4, 1
hypercholesterolemiasmoking habit108.13 *3, 2, 5
blood hypertensionthyroid diseases118.94 *2, 7, 2
blood hypertensionsmoking habit108.13 *2, 3, 5
thyroid diseasessmoking habit32.44 *2, 1, 0
Table 4. Distribution of patients with three risk factors (* = p < 0.05).
Table 4. Distribution of patients with three risk factors (* = p < 0.05).
Risk Factor 1Risk Factor 2Risk Factor 3No. of Patients% of PatientsTear Size
(S, L, M)
diabetesvenous system diseasescardiovascular diseases00.000, 0, 0
diabetesvenous system diseaseshypercholesterolemia12.330, 0, 1
diabetesvenous system diseasesblood hypertension00.000, 0, 0
diabetesvenous system diseasesthyroid diseases12.331, 0, 0
diabetesvenous system diseasessmoking habit00.000, 0, 0
diabetescardiovascular diseaseshypercholesterolemia00.000, 0, 0
diabetescardiovascular diseasesblood hypertension36.98 *2, 1, 0
diabetescardiovascular diseasesthyroid diseases00.000, 0, 0
diabetescardiovascular diseasessmoking habit00.000, 0, 0
diabeteshypercholesterolemiablood hypertension818.60 *4, 2, 2
diabeteshypercholesterolemiathyroid diseases12.331, 0, 0
diabeteshypercholesterolemiasmoking habit24.65 *1, 0, 1
diabetesblood hypertensionthyroid diseases00.000, 0, 0
diabetesblood hypertensionsmoking habit24.65 *1, 1, 0
diabetesthyroid diseasessmoking habit00.000, 0, 0
venous system diseasescardiovascular diseaseshypercholesterolemia24.65 *0, 2, 0
venous system diseasescardiovascular diseasesblood hypertension24.65 *1, 0, 1
venous system diseasescardiovascular diseasesthyroid diseases00.000, 0, 0
venous system diseasescardiovascular diseasessmoking habit00.000, 0, 0
venous system diseaseshypercholesterolemiablood hypertension12.330, 1, 0
venous system diseaseshypercholesterolemiathyroid diseases12.331, 0, 0
venous system diseaseshypercholesterolemiasmoking habit00.000, 0, 0
venous system diseasesblood hypertensionthyroid diseases12.330, 1, 0
venous system diseasesblood hypertensionsmoking habit24.65 *0, 1, 1
venous system diseasesthyroid diseasessmoking habit00.000, 0, 0
cardiovascular diseaseshypercholesterolemiablood hypertension511.63 *2, 0, 3
cardiovascular diseaseshypercholesterolemiathyroid diseases00.000, 0, 0
cardiovascular diseaseshypercholesterolemiasmoking habit00.000, 0, 0
cardiovascular diseasesblood hypertensionthyroid diseases00.000, 0, 0
cardiovascular diseasesblood hypertensionsmoking habit24.65 *0, 0, 2
cardiovascular diseasesthyroid diseasessmoking habit00.000, 0, 0
hypercholesterolemiablood hypertensionthyroid diseases716.28 *3, 3, 1
hypercholesterolemiablood hypertensionsmoking habit24.65 *0, 0, 2
hypercholesterolemiathyroid diseasessmoking habit00.000, 0, 0
blood hypertensionthyroid diseasessmoking habit00.000, 0, 0
Table 5. Distribution of patients according to tear size and presence of risk factors.
Table 5. Distribution of patients according to tear size and presence of risk factors.
Tear Size
No. of Risk FactorsSmall (%)Large (%)Massive (%)
097 (50.0%)55 (28.4%)42 (21.7%)
≥1113 (33.9%)118 (35.4%)102 (30.6%)
Table 6. Distribution of massive cuff tears among patients depending on the number of risk factors.
Table 6. Distribution of massive cuff tears among patients depending on the number of risk factors.
Number of Risk Factors% of Massive Tears
021.6%
131.9%
227.6%
332.6%
447.1%
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Gumina, S.; Orsina, L.; Song, H.-S.; Kim, H.; Bartocci, D.; Candela, V. Rotator Cuff Tear Size: Could It Be Influenced by the Presence of One or More Diseases Capable of Altering the Peripheral Microcirculation? J. Clin. Med. 2024, 13, 5965. https://doi.org/10.3390/jcm13195965

AMA Style

Gumina S, Orsina L, Song H-S, Kim H, Bartocci D, Candela V. Rotator Cuff Tear Size: Could It Be Influenced by the Presence of One or More Diseases Capable of Altering the Peripheral Microcirculation? Journal of Clinical Medicine. 2024; 13(19):5965. https://doi.org/10.3390/jcm13195965

Chicago/Turabian Style

Gumina, Stefano, Luigi Orsina, Hyun-Seok Song, Hyungsuk Kim, Daniele Bartocci, and Vittorio Candela. 2024. "Rotator Cuff Tear Size: Could It Be Influenced by the Presence of One or More Diseases Capable of Altering the Peripheral Microcirculation?" Journal of Clinical Medicine 13, no. 19: 5965. https://doi.org/10.3390/jcm13195965

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop